Affiliated with a Castle Connolly Top Hospital
Who is Dr. Hunt, Cardiologist in Palo Alto, CA?
Dr. Sharon Hunt, MD is a Cardiologist, who primarily practices in Palo Alto, CA. She is board certified. Dr. Hunt graduated from Stanford University School of Medicine and completed her residency at Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine. Dr. Hunt is fluent in English, and is currently seeing new patients. Dr. Hunt’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Hunt’s office at (650) 498-6605.
What are Areas of Expertise for Dr. Hunt?
Dr. Sharon Hunt, MD is a highly-rated, board-certified Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Hunt empowers patients to confidently navigate their health journey, specializing in Heart Failure, Transplant Medicine-Heart, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Hunt is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Hunt go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine | Stanford University Program
Medical School: Stanford Univ Sch Of Med- Stanford Ca | Stanford University School of Medicine
Is Dr. Hunt board certified as a Cardiologist?
Yes, Dr. Sharon Hunt, MD is board certified by the American Board of Internal Medicine
What languages does Dr. Hunt speak?
Dr. Hunt and their clinical team can communicate with patients in the following languages:
English
What conditions does a Cardiologist like Dr. Hunt typically treat?
As a Cardiologist, conditions treated by Dr. Sharon Hunt may include:
- Arrhythmia
- Atherosclerosis
- Atrial Fibrillation
- Carotid Stenosis
- Coronary Heart Disease
- Endocarditis
- Heart Attack
- Heart Disease
Please contact Dr. Hunt's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Cardiologist like Dr. Hunt typically perform?
As a Cardiologist, procedures performed by Dr. Sharon Hunt may include:
- Absent Pulmonary Valve Repair
- Anomalous Coronary Artery Angiography
- Anticoagulation Management
- Aortic Stenosis Repair
- Aortic Valve Repair / Replacement
- Aortopulmonary Window Repair
- Arterial Doppler
- Balloon Septostomy
Please contact Dr. Hunt's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Hunt accept my insurance?
Dr. Hunt accepts most major insurance plans. Important: Please call our office at (650) 498-6605 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Hunt accept in Palo Alto, CA?
Dr. Hunt in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Medicare
View All Insurances
Where is Dr. Hunt's office located?
Recognitions
Publications
Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute
, 2013
ST-Elevation Myocardial Infarction Following Heart Transplantation as an Unusual Presentation of
, 2013
Clinical and Functiol Correlates of Early Microvascular Dysfunction After Heart Transplantation
, 2012
Heart transplant recipient selection issues: Limited assets, infinite possibilities
, 2012
Comparison of Drug-Eluting Versus Bare Metal Stents in Cardiac Allograft Vasculopathy
, 2011
Behcet's disease and heart transplantation: A word of caution
, 2010
[Tratamiento basado en la evidencia de la insuficiencia cardiaca derecha: u revisión sistemática de
, 2010
Evidence-Based Magement of Right Heart Failure: a Systematic Review of an Empiric Field
, 2010
Changing trends in infectious disease in heart transplantation
, 2010
The Efficacy of Implantable Cardioverter
, 2009
Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodymically Compromising Rejection
, 2009
Twenty-year survivors of heart transplantation at Stanford University
, 2008
The changing face of heart transplantation
, 2008
Effect of rapamycin therapy on corory artery physiology early after cardiac transplantation
, 2008
Right ventricular function in cardiovascular disease, Part II - Pathophysiology
, 2008
Right ventricular function in cardiovascular disease
, 2008
Reversibility of trastuzumab cardiotoxicity: Is the concept alive and well? Reply
, 2007
Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness
, 2007
Trastuzumab-related cardiotoxicity: Calling into question the concept of reversibility
, 2007
Changes in corory atomy and physiology after heart transplantation
, 2007
Interplay between systemic inflammation
, 2007
Pulmory nocardiosis in a heart transplant patient: Case report and review of the literature
, 2007
Giant corory aneurysms in heart transplantation
, 2006
Taking heart - Cardiac transplantation past, present, and future
, 2006
Discordant changes in epicardial and microvascular corory physiology after cardiac transplantation
, 2006
Wound healing complications with de novo sirolimus versus mycophenolate mofetil
, 2006
Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis
, 2006
Use of the implantable cardioverter-defibrillator in long
, 2005
Glucose intolerance, as reflected by hemoglobin A(1c) level
, 2004
Cardiac xenotransplantation
, 2004
Alysis of survivors more than 10 years after heart transplantation in the cyclosporine era
, 2004
The impact of brain death on survival after heart transplantation: Time is of the essence
, 2003
Longer-term risks associated with 10
, 2003
Simultaneous assessment of fractiol
, 2003
Post-operative conversion from cyclosporine to tacrolimus in heart transplantation
, 2003
Long-term results of heart transplantation in patients older than 60 years
, 2003
Effect of a change in gender on corory arterial size
, 2003
Maligncy in organ transplantation: Heart
, 2002
Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection
, 2002
Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients
, 2002
Mycophenolic acid concentrations in long-term heart transplant patients
, 2002
Comment--the REMATCH trial
, 2002
Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation
, 2001
Infectious complications among 620 consecutive heart transplant patients at Stan
, 2001
Mild hyperhomocysteinemia is not associated with cardiac allograft corory disease
, 2001
Severe tricuspid regurgitation after heart transplantation
, 2001
Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of
, 2001
ACC/AHA tuidelines for the evaluation and magement of chronic heart failure in the adult
, 2001
Who and when to consider for heart transplantation.
, 2001
Neoplasia after heart transplantation.
, 2000
New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
, 2000
Determints of corory remodeling in transplant corory disease
, 2000
Primary bronchogenic carcinoma after heart or lung transplantation
, 2000
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant
, 1999
Thirty years of cardiac transplantation at Stanford University
, 1999
Current status of cardiac transplantation
, 1998
Mechanical circulatory support and cardiac transplantation
, 1998
Heart Retransplantation.
, 1998
Importance of decreased heart rate in predicting transplant corory artery disease
, 1997
Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection
, 1997
Pulmory hypertension in severe congestive heart failure: How important is it?
, 1997
Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life
, 1997
Relation of donor age and preexisting corory artery disease on angiography and intracorory
, 1997
Significant reduction in the number of fungal infections after lung-, heart-lung
, 1997
Methotrexate or total lymphoid radiation
, 1997
Early Doppler echocardiographic
, 1996
Early Doppler echocardiographic dysfunction is associated with an increased mortality after
, 1996
Are heart-lung transplant recipients protected from developing transplant corory artery disease? A
, 1996
Early development of accelerated graft corory artery disease: Risk factors and course
, 1996
Induction of nitric oxide synthase
, 1996
Corory artery intimal thickening in the transplanted heart
, 1996
Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections
, 1995
PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORORY ULTRASOUND AFTER CARDIAC
, 1995
HEART RETRANSPLANTATION - THE 25-YEAR EXPERIENCE AT A SINGLE INSTITUTION
, 1995
CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORORY
, 1995
CHARACTERISTICS OF PATIENTS SURVIVING MORE THAN 10 YEARS AFTER CARDIAC TRANSPLANTATION
, 1995
CLINICAL OUTCOME OF INTERVAL CADAVERIC REL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS
, 1995
CARDIAC ALLOGRAFT VASCULAR-DISEASE
, 1995
INCIDENCE AND SEVERITY OF TRANSPLANT CORORY
, 1995
DOES RAPIDITY OF DEVELOPMENT OF TRANSPLANT CORORY-ARTERY DISEASE PORTEND A WORSE PROGNOSIS
, 1994
CYTOKINES AS POTENTIAL MEDIATORS OF ACUTE ALLOGRAFT DIASTOLIC DYSFUNCTION IN CYCLOSPORINE
, 1994
IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION
, 1994
Recurrent lymphoma in a cardiac allograft recipient.
, 1994
CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA
, 1994
METABOLIC RISK-FACTORS FOR ATHEROSCLEROSIS IN HEART-TRANSPLANT RECIPIENTS
, 1994
LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION FOR PERIPARTUM CARDIOMYOPATHY
, 1994
INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORORY
, 1993
A PRELIMIRY-STUDY OF DILTIAZEM IN THE PREVENTION OF CORORY
, 1993
IMPACT OF PROXIMAL OR MIDVESSEL DISCRETE CORORY-ARTERY STENOSES ON SURVIVAL AFTER HEART
, 1992
ACCELERATED GRAFT CORORY-ARTERY DISEASE - DIAGNOSIS AND PREVENTION
, 1992
CARDIAC-FUNCTION AFTER DOMINO-DONOR HEART-TRANSPLANTATION
, 1992
COST CONTAINMENT - COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION
, 1992
CHARACTERISTICS OF SERIAL ELECTROCARDIOGRAMS IN HEART-TRANSPLANT RECIPIENTS
, 1991
TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION
, 1991
TRANSPLANT CORORY-ARTERY DISEASE - HISTOPATHOLOGIC CORRELATIONS WITH ANGIOGRAPHIC MORPHOLOGY
, 1991
LONG-TERM RESULTS OF CARDIAC TRANSPLANTATION
, 1991
INCREASED REJECTION IN GENDER-MISMATCHED GRAFTS - AMELIORATION BY TRIPLE THERAPY
, 1991
Progressive corory lumil rrowing after cardiac transplantation.
, 1990
PROGRESSIVE CORORY LUMIL RROWING AFTER CARDIAC TRANSPLANTATION
, 1990
Accelerated transplant corory artery disease.
, 1990
NONTUBERCULOUS MYCOBACTERIAL INFECTIONS IN HEART-TRANSPLANT RECIPIENTS - A 17-YEAR EXPERIENCE
, 1990
LONG-TERM CARDIOPULMORY FUNCTION AFTER HUMAN HEART-LUNG TRANSPLANTATION
, 1990
THE STANFORD EXPERIENCE - SURVIVAL AND REL
, 1990
CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES
, 1990
ACUTE MYOCARDIAL-INFARCTION IN CARDIAC TRANSPLANT RECIPIENTS
, 1989
Prevalence of accelerated corory artery disease
, 1989
PREVALENCE OF ACCELERATED CORORY-ARTERY DISEASE IN HEART
, 1989
FREQUENCY OF FAMILIAL TURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN
, 1989
INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS
, 1989
A HEMODYMIC AND DOPPLER ECHOCARDIOGRAPHIC STUDY OF VENTRICULAR-FUNCTION IN LONG
, 1989
RETRANSPLANTATION FOR SEVERE ACCELERATED CORORY-ARTERY DISEASE IN HEART-TRANSPLANT RECIPIENTS
, 1988
ACCELERATED CORORY VASCULAR-DISEASE IN THE HEART
, 1988
NONINVASIVE ASSESSMENT OF DONOR AND TIVE HEART FUNCTION AFTER HETEROTOPIC HEART-TRANSPLANTATION
, 1988
CARDIAC TRANSPLANTATION - UPDATE 1987
, 1987
CLINICAL AND LABORATORY CORRELATES OF ACCELERATED CORORY
, 1987
CHANGES IN DOPPLER ECHOCARDIOGRAPHIC INDEXES OF LEFT
, 1987
CARDIAC TRANSPLANTATION IN CHILDREN AND ADOLESCENTS
, 1987
Clinical and laboratory correlates of accelerated corory artery disease in the cardiac transplant
, 1987
Changes in Doppler echocardiographic indexes of left ventricular function
, 1987
Cardiac transplantation in children and adolescents.
, 1987
Cardiac sarcoidosis: response to steroids and transplantation.
, 1987
INFLUENCE OF RECIPIENT ATRIAL CONTRACTION ON LEFT
, 1987
HYPOXIC PULMORY VASOCONSTRICTION PERSISTS IN THE HUMAN TRANSPLANTED LUNG
, 1987
RESULTS OF IMMUNOCONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN HEART
, 1987
DOPPLER ECHOCARDIOGRAPHIC INDEXES OF DIASTOLIC FUNCTION AS MARKERS OF ACUTE CARDIAC REJECTION
, 1987
COMBINED HEART-LUNG TRANSPLANTATION FOR END-STAGE EISENMENGERS SYNDROME
, 1986
LATE RESULTS OF COMBINED HEART LUNG TRANSPLANTATION
, 1985
THE MECHANISMS OF VENTRICULAR
, 1985
LONG-TERM RESULTS, HEMODYMICS, AND COMPLICATIONS AFTER COMBINED HEART AND LUNG TRANSPLANTATION
, 1985
What is Dr. Hunt's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Hunt's National Provider Identifier (NPI) number is 1194879783.
What common questions do patients ask about Dr. Hunt?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Hunt
What is Dr. Sharon Hunt's specialty?
Dr. Hunt is a Cardiologist near Palo Alto, CA.
What does a Cardiologist do?
An internist specializing in cardiovascular diseases focuses on the diagnosis and management of complex heart and blood vessel conditions, including heart attacks and life-threatening arrhythmias.
Is this Dr. Sharon Hunt affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Hunt is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Cardiologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Sharon Hunt accepting new patients in Palo Alto, CA?
Yes, Dr. Sharon Hunt is accepting new patients at this time.
Does Dr. Sharon Hunt offer online booking?
Please contact Dr. Hunt's office at (650) 498-6605 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Sharon Hunt?
Please contact Dr. Hunt's office at (650) 498-6605 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Sharon Hunt have?
Dr. Sharon Hunt is certified by the American Board of Internal Medicine.
Other Cardiologist Near Palo Alto, CA
Cardiologist
Accepting patientsCardiologist
Accepting patientsCardiologist
Accepting patientsConnect with DR. Hunt
Falk Cardiovascular Research Building
300 Pasteur Dr
Palo Alto, CA 94305